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Yaws is an infectious disease found in South Amer-ica, Asia, Africa, and Oceania. It is caused by 
Treponema pallidum subspecies pertenue (1), an organ-
ism morphologically identical to T. pallidum subsp. 
pallidum, which causes syphilis. Yaws can manifest as 
skin lesions, involvement of the bones and joints, and 
eventually irreversible disfigurement. It is spread by 
direct contact between a susceptible person and le-
sions of infectious persons and particularly affects 
persons 2–15 years of age.
In the 1950s, the World Health Organization (WHO) 
and UNICEF led efforts to eradicate yaws through 
mass treatment with benzathine benzylpenicillin (2), 
reducing the number of cases worldwide by ≈95% (3). 
Yaws then fell off the public health agenda and has since 
resurged in several countries. Eradication efforts were 
renewed when, in 2012, a study (4) showed that treat-
ment with a single oral dose of azithromycin was nonin-
ferior to benzathine benzylpenicillin and did not require 
cold chains, injection equipment, or special training to 
administer, thus reducing the logistic barriers to mass 
drug administration and potentially making eradication 
more feasible.
In 2012, in response to this finding, member states 
of WHO committed to eradicate yaws by 2020 (5), al-
though more recently 2030 has been suggested as a 
more realistic target (6). The primary reason for this 
change was the high number of countries in which yaws 
is still endemic, and the even higher number of previ-
ously yaws-endemic countries whose current endemic-
ity status is currently unknown. The current eradication 
strategy, known as the Morges strategy, consists of treat-
ment with single-dose oral azithromycin in 2 modes of 
community-based intervention: total community treat-
ment (TCT) and total targeted treatment (TTT) (7). TCT 
attempts to treat everyone in a given community (vil-
lage or town) regardless of the number of active clinical 
cases, whereas TTT treats active clinical case-patients 
and their contacts, where contacts are those in the same 
household or school or are playmates of affected per-
sons (8). In response to evidence from pilot studies that 
a single round of TCT is not sufficient to interrupt trans-
mission, WHO has proposed revising the strategy (9). 
The revised strategy suggests that, in most circumstanc-
es, 2–3 rounds of TCT are likely to be required, followed 
by TTT performed at intervals of 6–12 months (9). TCT 
is designed for situations in which a large proportion of 
the population is infected, whereas TTT is intended to 
treat a small number of remaining cases once elimina-
tion of transmission (EOT) appears close.
T. pallidum subsp. pertenue infection can be divid-
ed into active yaws and latent yaws. Active yaws can 
then be split further into primary, secondary, and ter-
tiary yaws (10). After an incubation period averaging 
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Yaws is a neglected tropical disease targeted for eradi-
cation by 2030. To achieve eradication, finding and treat-
ing asymptomatic infections as well as clinical cases is 
crucial. The proposed plan, the Morges strategy, involves 
rounds of total community treatment (i.e., treating the 
whole population) and total targeted treatment (TTT) (i.e., 
treating clinical cases and contacts). However, modeling 
and empirical work suggests asymptomatic infections of-
ten are not found in the same households as clinical cas-
es, reducing the utility of household-based contact tracing 
for a TTT strategy. We use a model fitted to data from 
the Solomon Islands to predict the likelihood of elimination 
of transmission under different intervention schemes and 
levels of systematic nontreatment resulting from the inter-
vention. Our results indicate that implementing additional 
treatment rounds through total community treatment is 
more effective than conducting additional rounds of treat-
ment of at-risk persons through TTT.
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21 days (range 9–90 days), primary yaws initially 
manifests as a papule at the site of inoculation. The 
papule then enlarges, lasting for 3–6 months. Early 
secondary yaws lesions might appear near the initial 
lesion and persist >6 months. These lesions heal spon-
taneously, leading to a noninfectious latent period 
that can last the remaining lifetime of the person (11). 
However, the state of latency can end at any time by 
the reappearance of infectious lesions. Tertiary yaws 
lesions are now rarely seen (12), but when they do 
manifest, they appear years after primary yaws and 
are often destructive but are noninfectious.
A considerable challenge for eradicating yaws is 
the existence of asymptomatic persons, who together 
harbor a large reservoir of infection. For each active 
case of yaws, as many as 6–10 cases of latent yaws 
might exist (13). If we are not treating the whole com-
munity, successfully treating clinical case-patients 
and latently infected persons is essential. The as-
sumption conceptually underlying TTT is that as-
ymptomatic persons are likely to be close contacts of 
existing clinical case-patients.
The difficulty of diagnosing latent yaws in adults 
also represents a challenge for researchers attempting 
to understand the dynamics of transmission. Sero-
logic testing cannot distinguish between syphilis and 
yaws infections; thus, only children <15 years of age 
typically have serologic tests performed (3).
In this article, we extend previous yaws modeling 
work by incorporating household structure and simula-
tions of eradication strategies into the model. We evalu-
ate the Morges strategy and variants of it for their suit-
ability in meeting the WHO goal of yaws eradication. 
We investigate the likely effect of different assumptions 
regarding coverage during rounds of TCT on the suc-
cess of a strategy and the effect systematic nonadher-
ence could have on its effectiveness. We also consider 
whether regular surveillance could be an effective com-
ponent of a program seeking to meet the WHO goal.
Methods
We adapted the Markov model developed by Dyson 
et al. (14). The model consists of houses, each contain-
ing several inhabitants. Persons might be classified 
as susceptible, infected and infectious, or asymptom-
atically infected but not infectious. Within each house-
hold, susceptible persons might become infected by 
other persons from within their household or from 
other households. From the infectious state, a person 
can either recover and reenter the susceptible state, or 
they can have onset of a latent infection, entering the 
asymptomatic state. From the asymptomatic state, per-
sons can either recover, entering the susceptible state, 
or the infectious lesions can recur, causing them to re-
enter the infectious state. These transitions are summa-
rized in Table 1 and Figure 1. In Dyson et al. (14) this 
model was fitted at steady state to data from the Solo-
mon Islands (13), using a presumed constant rate of 
between-household infection. In our study, we extend-
ed the model to include a dynamic rate of between-
household infection, which we assumed to be propor-
tional to the total prevalence of infectious persons in 
the population at a given time (Appendix, https://
wwwnc.cdc.gov/EID/article/26/11/19-1491-App1.
pdf). We took parameter values from posterior distri-
butions with maximum posterior value drawn from 
expert opinion and previous model-fitting to Solomon 
Islands data (14) (Table 2).
We considered a population of 5,000 households, 
with sizes distributed according to empirical data 
from the Solomon Islands (Figure 2), representing a 
population of ≈20,000 persons. Each treatment scheme 
consisted of several rounds of TCT, followed by sev-
eral rounds of TTT. During TTT, we defined a contact 
to be anyone in the same household as an infectious 
person. We assumed an optimistic coverage of 100% 
of active case-patients and their contacts given treat-
ment during rounds of TTT (a conservative assump-
tion under the hypothesis that TTT is not an effective 
strategy), TCT coverage of 80% (3), and azithromycin 
efficacy of 95% (10). We considered up to 10 rounds 
of TCT and up to 10 rounds of TTT. Treatment rounds 
would be scheduled, on the basis of WHO guidelines 
(9), at 6-month intervals, with all rounds of TCT be-
ing performed before any TTT. Using the Gillespie 
algorithm (15), simulations were run to steady state 
before starting treatment and then run for an addi-
tional 150 months to simulate the time remaining to 
 
Table 1. Permitted state transitions and state transition rates for steady state household model of yaws transmission* 
Description State transition Rate 
Infection, external (ε) and within-household (β) (S,I,A) → (S-1,I+1,A) 𝜀𝜀 + 𝛽𝛽𝛽𝛽𝑁𝑁 − 1 
Treatment/birth-death (S,I,A) → (S+1,I-1,A)  
Remission (S,I,A) → (S,I-1,A+1)  
Recurrence (S,I,A) → (S,I+1,A-1)  
Treatment/birth-death (S,I,A) → (S+1,I,A-1)  
*Methods described in Appendix (https://wwwnc.cdc.gov/EID/article/26/11/19-1491-App1.pdf). A, asymptomatically infected (but not infectious); I, infected 
and infectious; S, susceptible. 
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meet the 2030 deadline. We simulated each scenario 
2,240 times and took the mean of the results.
We then considered the effect of population size 
on the probability of campaign success (i.e., whether 
a specific treatment campaign would be more suc-
cessful in areas with greater or fewer persons). We 
considered population sizes ranging from 100 to 
50,000 households, using 2 rounds of TCT followed 
by 2 rounds of TTT.
Although coverage is likely to be important in 
determining how successful a mass treatment cam-
paign would be (16), recent modeling work has shown 
that the quality of coverage is also critical (17); for 
example, whether the same persons receive treatment 
in each round has a substantial effect on the likelihood 
of EOT. Treatment campaigns that repeatedly miss the 
same persons are said to have a high level of systemat-
ic nontreatment. Models of treatment campaigns usu-
ally assume that a random selection of persons receive 
treatment in each round. However, this likely overes-
timates the effectiveness of a TCT round. We therefore 
developed a framework, as laid out in Fitzpatrick et al. 
(18), for mass drug administration, in which we could 
control person-level treatment correlation between 
rounds (i.e., if a person is treated in 1 round, how likely 
are they to be treated in a subsequent round?). For the 
sake of illustration, we can consider the special cases 
in which the correlation coefficient (ρ) is 0 or 1. Where 
ρ = 0, treatment status in 1 treatment round is not asso-
ciated with the probability of treatment in subsequent 
treatment rounds, which are independent events. 
Where ρ = 1, in each treatment round, the same per-
sons are treated, and the same persons are not treated.
We investigated the effect of assigning different 
values to ρ on the modeled effectiveness of interven-
tion. For ρ>0, we considered treatment status only at 
household level. So, for ρ = 1, the same households 
(and everyone in those households) would be treated 
every round, whereas for 0<ρ<1, each person in the 
same household has the same probability of receiv-
ing treatment, which is different to the persons in 
other households.
We also considered the use of more frequent, 
lower-intensity treatment. This could be delivered 
Figure 1. Graphic representation of the model being used for yaws transmission. Each house shape indicates a household, and 
the number of shapes inside each indicates number of persons. Each person is either susceptible (S, green), infectious (I, red), or 
asymptomatic (A, blue). Close-up image at right shows details of model parameters (see Tables 1, 2).
 
Table 2. Parameter values for household structured yaws 
transmission model, based on data collected from the Solomon 
Islands* 
Parameter Value Source 
 0.0516  (13) 
 0.0513  (13) 
 0.185  (14,15) 
 0.0165  (13) 
† 0.004  (13) 
‡ 0.1669 Appendix 
*Given parameter value is the maximum posterior value of the distribution 
from which each parameter is drawn, with the exception of  which is 
consistent with expert opinion. Methods described in Appendix 
(https://wwwnc.cdc.gov/EID/article/26/11/19-1491-App1.pdf). 
†Steady state external force of infection. 
‡Between-household rate of infection corresponding to a steady state 
external force of infection ε. 
 
RESEARCH
2688 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 26, No. 11, November 2020
by, for example, a volunteer offering azithromycin 
to persons who the volunteer thinks have yaws. We 
investigated whether this treatment would reduce 
the required number of rounds of TTT by using an 
estimated coverage of 5% of infectious persons and 
their household contacts every month, in addition to 
rounds of TCT/TTT every 6 months (up to 10 rounds 
of TCT, and up to 10 rounds of TTT).
Results
We first consider the dynamics under 3 different 
treatment strategies, chosen as strategies that have 
been previously discussed by yaws experts. These 
strategies, and the probability of EOT calculated for 
each, are summarized in Table 3. Although an extra 
round of treatment of either kind is beneficial, an ex-
tra round of TCT outperforms an extra round of TTT 
(Figure 3). In Figure 4, we plot EOT probability for 
up to 8 additional rounds of TCT or TTT, from a base 
intervention of 2 rounds of TCT and 2 rounds of TTT. 
Increasing the number of rounds of TCT increases the 
probability of EOT more rapidly than including ad-
ditional rounds of TTT. In fact, an additional 4–5 TTT 
rounds would be required to achieve the same effect 
as 1 additional round of TCT.
We extend this further by comparing the effective-
ness of 120 different treatment strategies, plus a control 
strategy in which no antibiotic treatment is provided, 
in a population of 5,000 households. Any strategy in-
volving <3 rounds of TCT is unlikely to be effective in 
meeting the 2030 WHO goal for yaws (Figure 5). When 
we assume a TCT coverage of 90%, we still find that 
>3 rounds should be considered (Appendix). TTT does 
not directly precipitate EOT by treating all cases. In-
stead, multiple rounds of TTT serve to keep infection 
prevalence low, so that in a small population infection 
eventually disappears stochastically. Effective popula-
tion size therefore influences the probability of EOT 
(i.e., infection in a smaller population is more suscep-
tible to stochasticity). Effective population size refers to 
the population that interacts, so that an isolated small 
village will have a small population size, whereas 
multiple villages sharing schools with substantial be-
tween-village intermingling have a larger effective size 
than the individual villages.
Figure 6 shows EOT probability with changing 
effective population size using a fixed strategy of 2 
rounds of TCT followed by 2 rounds of TTT. As the 
effective population size increases, the probability of 
EOT decreases, with the probability approaching 0 at 
≈10,000 households.
As coverage becomes more systematic (so that 
treatments tend to be given repeatedly to the same 
persons), the number of cases increases and the prob-
ability of EOT decreases substantially (Figure 7). Al-
though random coverage resulted in a probability of 
EOT of 15%, this result fell to 2% with fully system-
atic coverage. Each scheme we considered consists of 
2 rounds of TCT followed by 2 rounds of TTT. As the 
correlation between rounds of treatment increases, the 
probability of EOT decreases substantially, particularly 
for lower correlations, as we start moving away from 
random to more systematic treatment (Figure 8).
Since TTT primarily acts by keeping the in-
fectious population at a sufficiently low level that 
stochasticity eventually leads to elimination, we 
hypothesize that a lower level of more frequent 
treatment might act as a potential replacement 
for TTT. We consider the strategies investigated 
(Table 3), this time incorporating a monthly vol-
unteer treatment with a coverage of 5% (Table 
4). Under a strategy of 2 rounds of TCT followed 
by 2 rounds of TTT, the probability of elimina-
tion increased from 15% to 53% when we in-
corporated this low-level regular treatment, an 
increase of 38 percentage points. Similar increases 
were observed for the other 2 strategies. We noted 
a very small increase in probability of elimination 
achieved when performing a third round of TTT, 
suggesting that TTT has very limited effect with 
this volunteer treatment. Extending this to the 
full range of strategies previously considered, we 
 
Table 3. Summary of yaws treatment strategies* 
Strategy 
Rounds of 
TCT 
Rounds of 
TTT 
Probability of 
elimination 
1 2 2 15% 
2 3 2 57% 
3 2 3 26% 
*As shown in Figure 3 (https://wwwnc.cdc.gov/EID/article/26/11/19-1491-
F3.htm). TCT, total community treatment; TTT, total targeted treatment. 
 
Figure 2. Distribution of household sizes in the model being used 
for yaws transmission, based on data collected from the Solomon 
Islands in 2013.
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observe that additional rounds of TTT have a re-
duced effect compared with interventions without 
background treatment (Figure 9). Further reduc-
tions in impact are observed when more rounds 
of TCT are undertaken (Figures 10, 11). When per-
forming 2 rounds of TCT, increasing volunteer cov-
erage leads to increased probabilities of EOT un-
less >5 rounds of TTT are undertaken. When using 
4 rounds of TCT, increasing the number of rounds 
of TTT performed results in very little increase in 
the probability of EOT, regardless of the number of 
rounds of TTT performed.
Discussion
We used a stochastic household-level model of yaws 
transmission to consider the likely effectiveness of 
various treatment strategies in the eradication of 
yaws. As expected, we found that more rounds of 
TCT and TTT led to higher probability of EOT. How-
ever, in our model, EOT was not directly achieved 
through treatment itself. Rather, TTT served to keep 
the infection prevalence low, so that yaws eventually 
disappeared through chance events (i.e., TCT acts 
to reduce the prevalence of infection to a low level, 
which is then maintained by TTT until elimination 
Figure 3. Dynamics of yaws 
transmission (clinical infectious 
and latent cases combined, 
averaged over 1,000 simulations) 
under 3 different treatment 
strategies: 2 TCT, 2 TTT (red); 3 
TCT, 2 TTT (blue); 2 TCT, 3 TTT 
(green). A) All parameters tested; 
B) close-up showing detail of 
results. Simulations are run to 
steady state before starting the 
first round of treatment. Times 
given are the amount of time 
(in years) since the first round 
of treatment. Parameters are 
inferred from data collected from 
the Solomon Islands in 2013. 
TCT, total community treatment; 
TTT, total targeted treatment.
Figure 4. Probability of local elimination of transmission under 
different intervention strategies consisting of >2 rounds of TCT 
and >2 rounds of TTT, with varying numbers of additional rounds 
of TTT (blue) or TCT (green). Each twice-yearly round of TCT 
has 80% coverage, whereas TTT has 100% coverage and 
treatment is assumed to have 95% efficacy. All rounds of TCT are 
performed first before any rounds of TTT begin, which are then 
also performed twice yearly. Parameters are inferred from data 
collected from the Solomon Islands in 2013. TCT, total community 
treatment; TTT, total targeted treatment.
Figure 5. Probability of local elimination of transmission under 
different intervention strategies with varying numbers of rounds 
of TCT followed by rounds of TTT treating clinical case-patients 
and household contacts. Each rectangle in the figure represents 
a different strategy (consisting of some number of rounds of TCT 
followed by rounds of TTT). The color of the rectangle shows 
the probability of elimination of transmission, based on the 
color bar to the right. Each twice-yearly round of TCT has 80% 
coverage, whereas TTT has 100% coverage and treatment is 
assumed to have 95% efficacy. Parameters are inferred from data 
collected from the Solomon Islands in 2013. TCT, total community 
treatment; TTT, total targeted treatment.
RESEARCH
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occurs). As such, TCT should be considered the 
principal driving force for EOT. To efficiently reach 
elimination, according to our model, multiple rounds 
of TCT need to be implemented, and TTT should 
not be considered an effective method for reducing 
prevalence of infection. Indeed, it would take up to 
5 rounds of TTT to achieve the same effect as 1 ad-
ditional round of TCT. The original Morges strat-
egy, in which only a single round of TCT is advised, 
is unlikely to enable us to meet the WHO 2030 goal. 
However, the revised strategy, in which 2–3 rounds 
of TCT are advised, is more likely to meet this goal 
if linked to appropriate ongoing surveillance after 
TCT. However, further rounds of TCT will likely be 
required if 90% coverage is not attained. This conclu-
sion is consistent with the conclusions of previous 
modeling work (using the same data) (14,16), and re-
cent empirical findings from Papua New Guinea (19).
Because the effect of chance events was found 
to be a critical factor in determining success, we next 
considered the effect of population size on the effective-
ness of an eradication campaign. We found that, for a 
given treatment scheme, the size of the population had a 
considerable influence on the probability of EOT (i.e., a 
given strategy is more likely to be successful for smaller 
than larger populations). The corollary of this finding 
is that the intervention strategy used in any context 
should be influenced by the size of the population being 
treated. This conclusion should be considered in parallel 
with the conclusion outlined above. For stochasticity to 
successfully drive EOT, the prevalence of infection after 
completion of the rounds of TCT needs to be sufficiently 
small. The larger the population, the greater will be the 
number of rounds of TCT required to reduce the infec-
tion prevalence to the appropriate threshold (Figure 6).
Although the effect of varying treatment coverage 
levels is widely appreciated, the critical importance of 
the quality of the coverage is less well understood. 
The effect of rounds of TCT will be modified by the 
Figure 6. Probability of local elimination of transmission for 
varying population sizes after 2 rounds of TCT followed by 2 
rounds of TTT, 6 months apart. TCT has 80% coverage, and TTT 
has 100% coverage, and treatment is assumed to have 95% 
efficacy. Parameters are inferred from data collected from the 
Solomon Islands in 2013. TCT, total community treatment; TTT, 
total targeted treatment.
Figure 7. Dynamics of infected yaws (clinical infectious cases 
and latent cases) under random (red) or fully systematic (blue) 
coverage when implementing mass drug administration. 
Simulations are run to steady state before starting the first round 
of treatment. Times given are the amount of time since the first 
round of treatment. Treatment involved 2 twice-yearly rounds 
of TCT, followed by 2 twice-yearly rounds of TTT. TCT has a 
coverage of 80%, whereas TTT has a coverage of 100% of all 
infectious persons and their household contacts. Azithromycin 
efficacy is assumed to be 95%. Shaded regions denote values 
within 1 SD of the mean value. Parameters are inferred from data 
collected from the Solomon Islands in 2013. TCT, total community 
treatment; TTT, total targeted treatment.
Figure 8. Probability of local elimination of transmission under 
intervention strategy consisting of 2 rounds of TCT, followed by 2 
rounds of TTT treating clinical cases and household contacts as 
correlation between treatment rounds varies. 0 correlation denotes 
random treatment, whereas a correlation of 1 denotes fully 
systematic treatment. Each twice-yearly round of TCT has 80% 
coverage, whereas TTT has 100% coverage, and treatment is 
assumed to have 95% efficacy. Parameters are inferred from data 
collected from the Solomon Islands in 2013. TCT, total community 
treatment; TTT, total targeted treatment.
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 26, No. 11, November 2020 2691
Modeling Strategies to Inform Yaws Eradication
coverage attained and the level of systematic nontreat-
ment. When we assume treatment with some level of 
systematic nontreatment, we find that treatment is sub-
stantially less effective, given that under these schemes 
the same persons are treated many times, whereas oth-
ers are never treated. Because any treatment campaign 
will likely suffer from some level of systematic non-
treatment (in terms of correlation of treatment status 
between different treatment rounds), programs need 
to take this into account. As such, when undertaking a 
treatment campaign, maximizing not just the coverage 
of the campaign but also the quality of that coverage 
is beneficial. In short, if we always treat the same per-
sons and miss the same persons, a perpetual reservoir 
of infection might be maintained, undercutting efforts 
to interrupt transmission.
Because TTT primarily acts by keeping the infec-
tious population at a sufficiently low level that stochas-
ticity eventually leads to elimination, we hypothesized 
that a lower level of more frequent treatment might act 
as a potential replacement for TTT. This end could be 
accomplished through volunteers handing out azithro-
mycin to infected persons and their household con-
tacts on a monthly (or more frequent) basis. We found 
this approach to be very effective (theoretically) in in-
creasing the probability of EOT. Once the prevalence 
of infection was at a sufficiently low level, 5% cover-
age with ongoing treatment was sufficient to maintain 
that prevalence until infection was eliminated because 
of chance. After >4 rounds of TCT, this finding was 
valid regardless of whether any TTT was performed, 
perhaps indicating that TTT is redundant. This finding 
further supports the concept that additional rounds 
of TCT could be prioritized over TTT, particularly if 
low-level background antibiotic treatment could be 
subsequently deployed. Strategies to support ongoing 
community surveillance deserve further consideration 
and could link with ongoing regular surveillance for 
other neglected tropical diseases (20,21). This approach 
is supported by a successful elimination campaign in 
India, in which cash incentives were offered to persons 
who identified persons with confirmed cases.
Our study has several limitations, which might be 
addressed in future work. First, we defined a TTT con-
tact as a person in the same household as an infectious 
person. Extending this to include multiple nearby house-
holds, villages, or schools might affect model results. 
Treating school contacts could be particularly relevant 
because most new cases of yaws are found in children, 
which could suggest schools are important settings for 
transmission. Second, our model includes adults and 
children in a single class; however, given age-stratified 
data, we could model treatment effectiveness separately 
for adults and children, resulting in, for example, age-
dependent treatment strategies, such as only treating 
children, which has been empirically tested for the use 
of azithromycin in trachoma elimination (22). Higher 
coverage could be more reasonably achieved in young-
er age groups by yaws programs if this extension of the 
contact definition was incorporated. Third, spatial het-
erogeneities might play a role in affecting the transmis-
sion of yaws. In parts of the Solomon Islands, persons 
generally live near the coast and rarely walk through 
 
Table 4. Summary of yaws treatment strategies with and without regular surveillance* 
Strategy Rounds of TCT Rounds of TTT Volunteer treatment coverage Probability of elimination 
1a 2 2 0% 15% 
1b 2 2 5% 53% 
2a 3 2 0% 57% 
2b 3 2 5% 71% 
3a 2 3 0% 26% 
3b 2 3 5% 56% 
*Strategies labeled “a’” are those without any regular surveillance, whereas “b” indicates the corresponding strategy with regular surveillance. TCT, total 
community treatment; TTT, total targeted treatment. 
 
Figure 9. Probability of local elimination of transmission under 
different intervention strategies with varying numbers of rounds 
of TCT followed by rounds of TTT treating clinical case-patients 
and household contacts. Each rectangle in the figure represents 
a different strategy (consisting of some number of rounds of TCT 
followed by rounds of TTT). The color of the rectangle shows the 
probability of elimination of transmission, based on the color bar 
to the right. Each twice-yearly round of TCT has 80% coverage, 
whereas TTT has 100% coverage, and treatment is assumed 
to have 95% efficacy. An additional type of treatment round is 
administered once a month, giving treatment to 5% of infectious 
persons and their household contacts. Parameters are inferred 
from data collected from the Solomon Islands in 2013. TCT, total 
community treatment; TTT, total targeted treatment.
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the center of the island. Because an implementation unit 
is likely to consist of several villages, the population’s 
spatial distribution and movement patterns might limit 
the spread of infection. Including this information in 
our analyses could potentially more closely reflect real-
world transmission dynamics.
Reintroduction of yaws from outside the imple-
mentation site, although not directly relevant to our 
research question (which relates to the optimal con-
trol strategy within a given area), is possible and 
should be kept in mind for future yaws modeling 
work. Similarly, recent reports suggest that nonhu-
man primates can be reservoirs for yaws bacteria. If 
further evidence that transmission from nonhuman 
primates to humans is found, such findings should be 
considered in future models.
Recent reports have shown that as with the T. pal-
lidum subsp. palldium bacteria that cause syphilis, the 
T. pallidum subsp. pertenue bacteria that cause yaws can 
develop azithromycin resistance (19,23). Although peni-
cillin would remain effective in this scenario, such resis-
tance is an important concern for yaws eradication, and 
how likely implementation strategies are to generate 
resistance is a critical research question. Although drug 
resistance is currently a lesser concern than the relapse 
of latent infection, which is what we investigated in 
this study, collection of further data on drug resistance 
should be prioritized so that this possibility can be in-
vestigated and incorporated into future models.
In summary, we have shown that the current 
iteration of the Morges strategy is unlikely to help 
programs meet the WHO 2030 goal of global yaws 
eradication. We have suggested alternative strate-
gies that might increase the likelihood of achieving 
this goal. In particular, we found that further rounds 
of TCT should be preferred to TTT. We have also 
shown that population size and quality of coverage 
can greatly affect the success of a treatment cam-
paign and thus need to be considered in program 
design. Finally, further consideration should be giv-
en to strategies supporting ongoing community sur-
veillance, which could be integrated with ongoing 
surveillance for other neglected tropical diseases.
We made use of computing resources provided by the 
University of Warwick’s Scientific Computing Research 
Technology Platform.
M.M. was supported by the Wellcome Trust (grant no. 
102807/Z/13/Z). A.W.S. was supported by a Wellcome 
Trust Intermediate Clinical Fellowship (grant no. 098521). 
Our data set was derived from fieldwork in the Solomon 
Islands, which was supported in part by the UK  
Department for International Development, through 
the Global Trachoma Mapping Project (grant no. ARIES 
203145 to Sightsavers). The Global Trachoma Mapping 
Project was also supported by the US Agency for  
International Development, through the ENVISION 
project implemented by RTI International (cooperative 
agreement no. AID-OAA-A-11-00048), and the END (End 
Neglected Tropical Diseases) in Asia project implemented 
by FHI360 (cooperative agreement no. OAA-A-10-00051). 
A.H. is funded by the Engineering and Physical Sciences 
Research Council and the Medical Research Council 
through the MathSys CDT (grant no. EP/L015374/1).
Figure 10. Probability of eradication under a strategy of 2 rounds 
of TCT with a varying number of rounds of TTT. Additional 
treatment rounds have coverages of 0% (blue), 1% (yellow), 2% 
(green), 3% (red), 4% (purple), and 5% (brown). Low-coverage 
treatment of infected persons and their household contacts occurs 
once a month. Parameters are inferred from data collected from 
the Solomon Islands in 2013. TCT, total community treatment; 
TTT, total targeted treatment.
Figure 11. Probability of eradication under a strategy of 4 rounds 
of TCT with a varying number of rounds of TTT. Additional 
treatment rounds have coverages of 0% (blue), 1% (yellow), 2% 
(green), 3% (red), 4% (purple), and 5% (brown). Low-coverage 
treatment of infected persons and their household contacts occurs 
once a month. Parameters are inferred from data collected from 
the Solomon Islands in 2013. TCT, total community treatment; 
TTT, total targeted treatment.
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